Biotechnology Biohaven Presentation at AAN Showed Decreased Opioid Use in Migraine Patients Following Nurtec® ODT Therapy: A Real-World Administrative Claims Analysis April 7, 2022
Biotechnology Alkermes Presents New Data From Psychiatry Portfolio at 2022 Congress of the Schizophrenia International Research Society April 7, 2022
Biotechnology Biohaven Expands Commitment to Supporting Veterans and Military Through Sole Sponsorship of National Headache Foundation’s (NHF) Outreach Program April 6, 2022
Biotechnology Adaptive Biotechnologies to Report First Quarter Financial Results on May 4, 2022 April 5, 2022
Search
Biotechnology
